MedTrace Logo

Plasma Hepcidin Response to Differently Dosed Iron Supplements

NCT04735848 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-10-08

No results posted yet for this study

Summary

The study participants will take 3 different doses of iron supplements at 8 am, on 3 different days. By taking blood samples in the morning and afternoon, the investigators will determine the effects of the iron supplements on plasma hepcidin and compare them to baseline plasma hepcidin values.

Conditions

  • Iron Deficiency (Without Anemia)

Interventions

DIETARY_SUPPLEMENT

Iron-supplement application

The participants will take the corresponding amount of iron-supplement supervised at 8am.

Sponsors & Collaborators

  • Pierre-Alexandre Krayenbuehl

    lead OTHER

Principal Investigators

  • Pierre-Alexandre Krayenbühl · University of Zurich

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2021-08-31
Completion
2021-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04735848 on ClinicalTrials.gov